Cantor Fitzgerald analyst Craig Bijou raised his price target for Wright Medical Group to $39 citing the company’s “encouraging” 2019 guidance. The analyst believes Wright Medical posted “solid” Q4 results, with strength across each of its segments. He continues to believe the company “has multiple drivers to accelerate growth in 2019.” Bijou reiterates an Overweight rating on the shares.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.